Related Experiment Video

Updated: Aug 24, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

[Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma]

Li Li1, Yan-Ping Zhong, Wei Zhang

  • 1Department of Gynecologic Oncology, Affiliated Tumor Hospital, Guangxi Medical University, Nanning, Guangxi, 30021, PR China. lili_temp@hotmail.com

AI Zheng = Aizheng = Chinese Journal of Cancer
|May 15, 2004
PubMed
Abstract

Insights

The C-erbB family, including C-erbB2, C-erbB3, and C-erbB4, is significantly expressed in ovarian cancer, correlating with advanced stages and poorer patient survival. These findings highlight the C-erbB family

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The epidermal growth factor receptor family includes C-erbB2, C-erbB3, and C-erbB4.
  • C-erbB2 is linked to ovarian carcinoma, but the roles of C-erbB3 and C-erbB4 remain unclear.

Purpose of the Study:

  • To investigate the expression of C-erbB2, C-erbB3, and C-erbB4 in ovarian neoplasms.
  • To determine the relationship between the expression of these C-erbB proteins and clinicopathological parameters in ovarian cancer.

Main Methods:

  • Streptavidin-peroxidase immunohistochemistry was employed.
  • Expression levels were assessed in 49 malignant ovarian neoplasms, 21 benign neoplasms, and 19 normal ovarian tissues.
  • Statistical analysis correlated protein expression with clinicopathological features.

Main Results:

  • Significantly higher expression rates of C-erbB2, C-erbB3, and C-erbB4 were observed in malignant ovarian neoplasms compared to benign and normal tissues (P<0.05).
  • Expression levels did not significantly correlate with tumor pathological type or grade.
  • Elevated expression of C-erbB2, C-erbB3, and C-erbB4 was associated with advanced disease stage and larger ascites volume (>500 ml) (P<0.05).
  • Positive expression of C-erbB2 or C-erbB4 correlated with longer cumulative survival and were identified as independent prognostic factors for ovarian cancer (P<0.01).

Conclusions:

  • The C-erbB family plays a crucial role in the development of ovarian malignant neoplasms.
  • The expression of C-erbB family members is associated with a poor prognosis in ovarian cancer patients.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...